Featured News

Tailored by the Trace: How Measurable Residual Disease is Helping Guide Hematology Treatment

by Marc Astick, Associate Scientific Director and Rebecca Lamb, Senior Group Director Ask experts in hematology what they’re working towards and you’re likely to hear...

Scientific Trust Is Becoming Medical Affairs’ Most Valuable Asset

by Heather Shawcross, Associate Director, Medical Strategy, EMEA Strategy, Scientific & Medical The value challenge isn’t new. The environment is. Medical Affairs is the strategic...

Real Chemistry Appoints Healthcare Industry Leaders Frank Clyburn and Chris Fikry to Board of Directors

New independent directors bring deep experience in commercialization, data-driven transformation and growth NEW YORK, May 28, 2026 — Real Chemistry, a leader in AI-driven insights...

What Happens at ASCO Doesn’t Stay at ASCO

by Stephanie Holbrook, Senior Vice President, Activation, starpower Not that long ago, the conversation around a major ASCO readout unfolded over time. Data was presented...

AI Has Given Medical Affairs Everything Except the Answer

By Briana Belford, Practice Leader, Integrated Intelligence If you talked to me at all in Q1, you probably heard about all the travel, events and...

AI Is Now Between Your Publication and Your Audience

When thinking about publications, we’ve traditionally assumed clinicians go to journals or PubMed when they have a question. But now, we’re seeing something very different....

The Caregiver Imperative: The Invisible Workforce Shaping Neurological Care

By the time a neurologist sees a new patient, someone else has already been practicing medicine in the dark. They noticed the tremor that wouldn’t...

Medical Affairs Is Moving Into the Moment

What’s changing across data, engagement, and the pace of execution At the 2026 MAPS Annual Meeting, Medical Affairs teams described how their approach is changing....

Scientific Exchange in a Social World

What Med Comms teams need to know about modern platforms Medical Communications has always been about getting the science right. That part hasn’t changed. What’s...

2

…